A Pilot Study to Evaluate the Safety of Terbutaline in Children With Type 1 Diabetes
Status:
Completed
Trial end date:
2008-09-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to gain experience with the use of terbutaline in children with
T1D and to determine that there is not a frequent serious, unexpected, uncontrollable effect
on short-term glycemic control. Some information also will be obtained with regard to whether
terbutaline, in the dosing being used in the study, is sufficiently well tolerated to expect
that adherence will be satisfactory in a large randomized trial. In addition, this pilot
study will provide data on the accuracy of a continuous glucose monitor during terbutaline
use to verify that the drug does not impact on sensor function.
Phase:
Phase 1
Details
Lead Sponsor:
Jaeb Center for Health Research
Collaborator:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)